Pinpoint Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Pinpoint Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$5.02M	Sell	380,625 -96,250	-20%	-$1.33M	0.87%	18
2024 Q4	$7.53M	Buy	476,875 +457,500	+2,361%	+$6.87M	1.33%	19
2024 Q3	$308K	Buy	+19,375	New	+$312K	0.07%	54
2024 Q1	–	Sell	-23,750	Closed	-$331K	–	125
2023 Q4	$331K	Buy	+23,750	New	+$318K	0.07%	44

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pinpoint Asset Management's RDY Position: Q1 2025 in Review

Pinpoint Asset Management reduced its Dr. Reddy's Laboratories (RDY) stake by 20% in Q1 2025, selling an estimated $1.33M and leaving 380,625 shares worth $5.02M. The position accounts for 0.87% of the portfolio, ranked #18.

Pinpoint Asset Management first reported a position in RDY in Q4 2023 and has held it in 4 quarters since. The position peaked at $7.53M in Q4 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

Pinpoint Asset Management held 380,625 shares of Dr. Reddy's Laboratories worth $5.02M as of Q1 2025.
Pinpoint Asset Management sold 96,250 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $1.33M.
Dr. Reddy's Laboratories made up 0.87% of Pinpoint Asset Management's portfolio in Q1 2025, its #18 holding.
Pinpoint Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2023 and has held it in 4 quarters since.
Pinpoint Asset Management's Dr. Reddy's Laboratories position peaked at $7.53M in Q4 2024.
243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Pinpoint Asset Management's 13F filing for Q1 2025, filed 12 May 2025.